Continuing educational initiatives in colorectal cancer (CRC) have specifically been requested by the Veterans Affairs (VA) health care system. In the United States, CRC is the third most common tumor type. Screening is an important first step in reducing mortality because it may allow for the detection of CRC at earlier stages when the disease is usually asymptomatic. In recent years, advances in the understanding of tumor biology have resulted in the development of targeted approaches to manage metastatic CRC. Targeted therapies have been integrated into multiple treatment strategies for CRC and are being evaluated in different settings.
This program will evaluate contemporary methods that integrate targeted therapies into the treatment of patients with CRC. The current application of molecular markers in the management of metastatic disease will also be demonstrated. The goal of this program is to present case examples that are applicable to providing individualized care for patients with CRC.
Available until December 29, 2010, this activity offers:
Physicians: 1.0 AMA PRA Category 1 Credit™
Nurses: 1.0 contact hour
This activity is jointly sponsored by SCEPTER™ and Quintiles Medical Education. This activity is co-provided by Global Education Group and SCEPTER™.
[Back to top]
[Back to Activity Home]
|
